Last reviewed · How we verify
NCT03187522
An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft
NA trial testing TREO Stent-Graft System in Aortic Aneurysm, Abdominal in 174 participants. Terminated before completion.
30 December 2020
Quick facts
| Lead sponsor | Bolton Medical |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 174 |
| Start date | 22 June 2017 |
| Primary completion | 30 December 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 16 locations across Italy, Netherlands, Belgium, United Kingdom, Germany, Switzerland, Spain |
Drugs / interventions tested
- TREO Stent-Graft System
Conditions studied
- Aortic Aneurysm, Abdominal — all drugs for Aortic Aneurysm, Abdominal →
Sponsor
Bolton Medical — full company profile →
Who can join
18 and older, any sex, with Aortic Aneurysm, Abdominal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an EU sponsored trial and independent of the US trial registered under Clinicaltrials.gov ID NCT02009644. The purpose of this registry is to gather clinical data on the safety and performance of the TREO Stent-Graft in patients with infrarenal abdominal aortic aneurysms. The registry is part of TREO's EU post-market surveillance plan providing long-term systematic clinical follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03187522
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aortic Aneurysm, Abdominal
Currently open trials in the same condition.
- NCT06488898 — Abdominal Aortic Aneurysm Stabilization With Truncal Cells: Controlled Clinical Trial With Historical Cohorts · Phase 2 · recruiting
- NCT05972018 — Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters · Phase 4 · recruiting
- NCT04503395 — ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES · NA · recruiting
- NCT05360108 — Screening for Abdominal Aortic Aneurysm and Popliteal Artery Aneurysm · active not recruiting
- NCT02489539 — Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms · NA · active not recruiting
Other Bolton Medical trials
Trials by the same sponsor.
- NCT07026877 — Endovascular Repair With Fenestrated TREO Stent-Graft System in AAA · NA · recruiting
- NCT04697784 — Post-Approval Study of the TREO Abdominal Stent-Graft System · NA · active not recruiting
- NCT03214601 — Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System · NA · active not recruiting
- NCT03090230 — Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta · NA · active not recruiting
- NCT02724072 — Thoraflex™ Hybrid IDE Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03187522 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bolton Medical
- Last refreshed: 3 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03187522.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing